460 476
[16]
Berney DM, Wheeler TM, Grignon DJ, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod Pathol 2011;24:39–47.
[17]
Srigley JR, Humphrey PA, Amin MB, et al. Protocol for the exami- nation of specimens from patients with carcinoma of the prostate gland. Arch Pathol Lab Med 2009;133:1568–76.[18]
Moussa AS, Li J, Soriano M, et al. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer. BJU Int 2009;103:43–8.
[19]
Siddiqui MM, Rais-Bahrami S, Turkbey B, et al. Comparison of MR/ ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015;313:390–7.
[20]
Meng X, Rosenkrantz AB, Mendhiratta N, et al. Relationship be- tween prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion-targeted pros- tate biopsy outcomes. Eur Urol 2016;69:512–7.
[21]
Tosoian JJ, Mamawala M, Epstein JI, et al. Intermediate and longer- term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. J Clin Oncol 2015;33:3379–85.[22]
Welty CJ, Cowan JE, Nguyen H, et al. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol 2015;193:807–11.
[23]
Klotz L, Vesprini D, Sethukavalan P, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 2015;33:272–7.
[24]
Vainer B, Toft BG, Olsen KE, et al. Handling of radical prostatectomy specimens: total or partial embedding? Histopathology 2011;58: 211–6.[25]
Kim K, Pak PJ, Ro JY, et al. Limited sampling of radical prostatectomy specimens with excellent preservation of prognostic parameters of prostate cancer. Arch Pathol Lab Med 2009;133:1278–84.
[26]
Hernandez DJ, Nielsen ME, Han M, et al. Natural history of patho- logically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy. Urology 2008;72:172–6.
[27]
Danneman D, Drevin L, Robinson D, et al. Gleason inflation 1998- 2011: a registry study of 97,168 men. BJU Int 2015;115:248–55.
[28]
Samaratunga H, Delahunt B, Gianduzzo T, et al. The prognostic significance of the 2014 International Society of Urological Pathol- ogy (ISUP) grading system for prostate cancer. Pathology 2015;47: 515–9.[29]
Kristiansen A, Wiklund F, Wiklund P, et al. Prognostic significance of patterns of seminal vesicle invasion in prostate cancer. Histopa- thology 2013;62:1049–56.
[30]
Kweldam CF, Wildhagen MF, Bangma CH, et al. Disease-specific death and metastasis do not occur in patients with Gleason score 6 at radical prostatectomy. BJU Int 2015;116:230–5.E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 4 5 5 – 4 6 0
460